IDSA Guidance on the treatment of antimicrobial-resistant Gram-Negative infections – A focus on extended-spectrum β-lactamase producing Enterobacterales, Carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance.
9 Mar, 2022 | 08:51h | UTCRelated:
IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.